NBRI clinical researchers are focused on developing and evaluating new treatments to optimize evidence-based care for current and future patients throughout the world.

Clinical trials, such as the ongoing HEAL trial of erythropoietin (Epo) for neuroprotection in term infants with hypoxic-ischemic encephalopathy (HIE), test the efficacy of new cutting-edge therapies for patients at risk for neurodevelopmental impairment.